Alamar Biosciences, Inc. (ALMR)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	74.21M
Net Income	-29.82M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ALMR

Alamar Biosciences is a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Our proprietary NULISA technology was purpose-built to address the limitations of existing proteomics tools by detecting protein biomarkers at extremely low concentrations in non-invasive biological fluids, such as blood, with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation. Our integrated platform consists of proprietary instruments, consumables and analytical s...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2018
• Employees: 222
• Stock Exchange: NASDAQ
• Ticker Symbol: ALMR
• Website: https://alamarbio.com/